Single nucleotide polymorphisms in the proximal promoter region of apolipoprotein M gene (apoM) confer the susceptibility to development of type 2 diabetes in Han Chinese

Diabetes/Metabolism Research and Reviews

Volumn 23, Issue 1, 2007, Pages 21-25

  Niu, Nifang ^a   Zhu, Xilin ^a   Liu, Yang ^a   Du, Te ^a   Wang, Xin ^a   Chen, Dongmei ^a   Sun, Bei ^a   Gu, Harvest F ^b   Liu, Ying ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Apolipoprotein M; Chinese; Genetic association; Haplotypes; Single nucleotide polymorphisms; Type 2 diabetes

Indexed keywords

APOLIPOPROTEIN M; CHOLESTEROL; GLUCOSE; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; VALIDATION PROCESS;

AGED; APOLIPOPROTEINS; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33846549168     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.641     Document Type: Article

References (13)

1. St-Pierre J, Vohl MC, Despres JP, et al., Genetic aspects of diabetes and its cardiovascular complications: contribution of genetics to risk assessment and clinical management. Can J Cardiol 2005; 21: 199-209.
2. John DB, Amir FA. Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus. Am J Med 2003; 115: 24S-28S.
3. Pickup JC, DPHIL, FRCPATH. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004; 27: 813-823.
4. Navab M, Anantharamaiah GM, Fogelman AM. The role of high-density lipoprotein in inflammation. Trends Cardiovasc Med 2005; 15: 158-161.
5. Xu N, Dahlbäck B. A novel human apolipoprotein (apoM). J Biol Chem 1999; 274: 31286-31290.
6. Duan JV, Dahlbäck B, Villoutreix BO. Proposed lipocalin fold for apolipoprotein M based on bioinformatics and site-directed mutagenesis. FEBS Lett 2001; 499: 127-132.
7. Wolfrum C, Poy MN, Stoffel M. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat Med 2005; 11: 418-422.
8. Xu N, Zhang XY, Dong X. Effects of platelet-activating factor, tumor necrosis factor, interleukin-1α on the expression of apolipoprotein M in HepG2 cells. Biochem Biophys Res Commun 2002; 292: 944-950.
9. Xu N, Hurtig M, Zhang XY, et al. Transforming growth factor-beta down-regulates apolipoprotein M in HepG2 cells. Biochim Biophys Acta 2004; 1683: 33-37.
10. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1. Diagnosis and Classification of Diabetes Mellitus. World Health Organization: Geneva, 1999.
11. Xu N, Nilsson-Ehle P, Ahren B. Correlation of apolipoprotein M with leptin and cholesterol in normal and obese subjects. J Nutr Biochem. 2004; 15: 579-582.
12. Richter S, Shih DQ, Pearson ER, et al. Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1α. Diabetes 2003; 52: 2989-2995.
13. Shih DQ, Bussen M, Sehayek E, et al. Hepatocyte nuclear factor-1α is an essential regulator of bile acid and plasma cholesterol metabolism. Nat Genet 2001; 27: 75-382.